Please enable Javascript
Hans Lee, MD
Articles by Hans Lee, MD
Hans Lee, MD, Covers Outcomes, Treatments After Triple-Class Exposure in Myeloma
Hans Lee, MD
Myeloma
|
December 19, 2023
Dr. Hans Lee met with Blood Cancers Today to discuss outcomes and treatments after triple-class exposure in multiple myeloma.
View More
Hans Lee, MD, on the LINKER-MM1 Study of Linvoseltamab in Multiple Myeloma
Cecilia Brown
Myeloma
|
September 5, 2023
The phase II study evaluated linvoseltamab, a bispecific antibody targeting BCMA and CD3, in relapsed or refractory MM.
View More